FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:851-854 February 22, 2007 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article Related Article by Calverley, P. M.A. PubMed Citation

In the United States, the overall, age-standardized death rate decreased from 1242 deaths per 100,000 population in 1970 to 845 deaths per 100,000 in 2002. This good news must be viewed against the doubling during the same interval of the age-standardized death rate among persons with chronic obstructive pulmonary disease (COPD),¹ which makes COPD a major cause of death (Figure 1).

View larger version (68K):   Figure 1. Causes of Death in Patients with COPD. Among patients with COPD, death can result from causes in a number of disease categories, in part, because of the strong association between COPD and exposure to cigarette smoke. In . . . [Full Text of this Article]

 

Source Information

From the Leiden University Medical Center, Leiden, the Netherlands.

This article has been cited by other articles:

• Gross, N. J. (2008). Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation. Mayo Clin Proc. 83: 1241-1250 [Abstract] [Full Text]  
• Suissa, S. (2008). Medications to Modify Lung Function Decline in Chronic Obstructive Pulmonary Disease: Some Hopeful Signs. Am. J. Respir. Crit. Care Med. 178: 322-323 [Full Text]  
• Sabroe, I, Parker, L C, Calverley, P M A, Dower, S K, Whyte, M K B (2008). Pathological networking: a new approach to understanding COPD. Postgrad. Med. J. 84: 259-264 [Abstract] [Full Text]  
• MacNee, W. (2008). Update in Chronic Obstructive Pulmonary Disease 2007. Am. J. Respir. Crit. Care Med. 177: 820-829 [Full Text]  
• Sabroe, I., Parker, L. C, Calverley, P. M A, Dower, S. K, Whyte, M. K B (2007). Pathological networking: a new approach to understanding COPD. Thorax 62: 733-738 [Abstract] [Full Text]  
• Maki, R. G., Wathen, J. K., Patel, S. R., Priebat, D. A., Okuno, S. H., Samuels, B., Fanucchi, M., Harmon, D. C., Schuetze, S. M., Reinke, D., Thall, P. F., Benjamin, R. S., Baker, L. H., Hensley, M. L. (2007). Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002. JCO 25: 2755-2763 [Abstract] [Full Text]  
• Rabe, K. F., Beghe, B., Luppi, F., Fabbri, L. M. (2007). Update in Chronic Obstructive Pulmonary Disease 2006. Am. J. Respir. Crit. Care Med. 175: 1222-1232 [Full Text]  
• Barnes, P. J., La Vecchia, C., Fabbri, L. M., Duerden, M., Kupfer, Y., Tessler, S., Keaney, N., Calverley, P., Anderson, J., Celli, B. (2007). Prevention of Death in COPD. NEJM 356: 2211-2214 [Full Text]  
• Kiley, J. P., Nabel, E. G. (2007). Treating COPD. NEJM 356: 867-867 [Full Text]  
• (2007). Inhaled Therapy and Mortality in COPD. JWatch General 2007: 1-1 [Full Text]